Heart Pump Devices Market Size & Growth Forecast 2027–2036, By Segments (Type, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Heart Pump Devices Market size was valued at USD 5.3 billion in 2026 and is anticipated to grow at a 10.55% CAGR from 2027 to 2036, reaching USD 14.45 billion by 2036. The industry revenue for 2027 is assessed at USD 5.77 billion.
Get more details on this report
Request Free Sample ReportHeart Pump Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 55.22% share due to advanced cardiac care infrastructure, specialized hospitals, and strong use of ventricular assist devices supported by high procedural volumes and monitoring systems.
- Asia Pacific is growing at 15.12% CAGR due to rising cardiovascular disease burden, improved access to advanced hospital care, and expanding adoption of device-based cardiac support in tertiary centers.
Segment Momentum
- Implanted Heart Pump Devices held a 67.03% market share in 2026 due to their established role in long-term mechanical circulatory support, supporting patient mobility and continuity of care beyond acute hospital treatment.
- Extracorporeal Membrane Oxygenation (ECMO) is the fastest-growing product segment, driven by increasing demand for immediate heart and lung support in critical care, emergency interventions, and complex short-term stabilization cases.
Market Expansion Drivers
- Rising prevalence of cardiovascular diseases increasing demand for ventricular assist devices.
- Expanding regulatory approvals for advanced heart pump devices accelerating clinical adoption.
- Growing integration of AI-assisted cardiac diagnostics improving heart failure intervention outcomes.
Leading Market Participants
- Key players in the heart pump devices market include Abbott Laboratories (United States), Abiomed, Inc. (United States), Getinge AB (Sweden), LivaNova PLC (United Kingdom), Berlin Heart GmbH (Germany), SynCardia Systems, LLC (United States), Jarvik Heart, Inc. (United States), BiVACOR Inc. (United States), Leviticus Cardio Ltd. (Israel), Teleflex Incorporated (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 5.3 billion
- 2027 Estimated Market Size: USD 5.77 billion.
- Projected Market Size: USD 14.45 billion by 2036
- Growth Forecast: 10.55% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Implanted Heart Pump Devices (Type) | Ventricular Assist Devices (VADs) (Product) | Hospitals (End-use)
- Emerging Opportunity Segment: Extracorporeal Heart Pump Devices (Type) | Extracorporeal Membrane Oxygenation (ECMO) (Product) | Cardiac Centers (End-use)
Market Growth Drivers and Industry Trends
Rising prevalence of cardiovascular diseases increasing demand for ventricular assist devices
The increasing incidence of cardiovascular diseases is creating a substantial need for advanced circulatory support, and the heart pump devices market is being supported by rising demand for ventricular assist devices among patients with severe cardiac dysfunction. As heart failure progresses in patients who have limited therapeutic options, mechanical circulatory support can provide assistance in maintaining adequate blood flow and reducing the strain placed on the heart. Greater clinical focus on managing advanced heart failure is therefore encouraging healthcare providers to consider heart pump technologies as part of treatment strategies for patients requiring prolonged or specialized cardiac support.
Expanding regulatory approvals for advanced heart pump devices accelerating clinical adoption
Broader regulatory approvals for innovative heart pump technologies are helping expand their availability for clinical use and will propel the heart pump devices market by improving physician access to advanced treatment options. Regulatory clearances provide greater clinical confidence in device safety, performance, and intended applications, while approvals across additional patient populations or treatment settings can expand the addressable use of mechanical circulatory support. As more advanced devices progress through regulatory pathways, healthcare institutions can incorporate newer heart pump solutions into treatment protocols for patients with complex cardiovascular conditions.
Growing integration of AI-assisted cardiac diagnostics improving heart failure intervention outcomes
The integration of artificial intelligence into cardiac diagnostics is strengthening the identification and management of heart failure, creating complementary demand for advanced mechanical support technologies. AI-assisted tools can help clinicians interpret cardiac information, recognize deterioration patterns, and support more timely intervention decisions, which will support heart pump devices market growth by improving patient selection and treatment planning. Greater use of data-driven cardiac assessment can also facilitate closer monitoring of patients with advanced disease, allowing healthcare teams to evaluate changes in cardiac function and determine when mechanical circulatory support may be appropriate.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of cardiovascular diseases increasing demand for ventricular assist devices | 2.40% | High | North America, Europe, Asia Pacific | High | Near Term |
| Expanding regulatory approvals for advanced heart pump devices accelerating clinical adoption | 2.00% | High | North America, Europe | High | Mid Term |
| Growing integration of AI-assisted cardiac diagnostics improving heart failure intervention outcomes | 1.60% | Moderate | North America, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the heart pump devices market with a 55.22% share in 2026, reflecting advanced cardiovascular healthcare infrastructure, high adoption of sophisticated medical devices, and strong demand for therapies addressing severe heart failure. The region has extensive access to specialized cardiac centers and advanced surgical capabilities, supporting the use of heart pump technologies in complex patient care. Increasing prevalence of cardiovascular conditions, continued investment in medical innovation, and improvements in device design are also contributing to sustained demand. Favorable clinical expertise and established treatment pathways further reinforce North America's leading market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region, supported by expanding healthcare infrastructure, improving access to advanced cardiac care, and rising awareness of treatment options for patients with severe cardiovascular conditions. Growing investments in specialized hospitals and cardiac treatment facilities are creating a stronger environment for the adoption of heart pump technologies. The region is also benefiting from increasing healthcare expenditure and the gradual expansion of advanced medical-device capabilities. As clinical expertise develops and access to sophisticated cardiovascular interventions improves, demand for heart pump devices is expected to gain momentum.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Specialized Cardiac CareGermany emphasizes heart pump device adoption within specialized cardiovascular centers performing complex heart failure interventions. Clinical teams prioritize technologies that integrate with established treatment pathways while supporting improved patient management and procedural precision.
France 🇫🇷
Integrated Heart Failure CareFrance prioritizes heart pump devices within multidisciplinary heart failure treatment programs that combine surgical expertise and long-term patient monitoring. Clinical adoption increasingly reflects efforts to optimize outcomes through coordinated cardiovascular care pathways.
Italy 🇮🇹
Cardiac Procedure EnhancementItaly expands heart pump device utilization by improving capabilities across tertiary care hospitals treating advanced cardiovascular conditions. Italian clinicians continue adopting technologies that strengthen procedural efficiency while supporting comprehensive heart failure management.
Japan 🇯🇵
Minimally Invasive AdoptionJapan advances heart pump device utilization by encouraging minimally invasive treatment approaches for patients requiring mechanical circulatory support. Hospitals continue evaluating compact device designs that complement evolving cardiovascular care practices and long-term clinical management.
South Korea 🇰🇷
Hospital Technology UpgradesSouth Korea strengthens the heart pump devices market through investments in advanced cardiac care infrastructure and specialized treatment programs. Healthcare providers increasingly adopt innovative support systems that enhance procedural capabilities for complex cardiovascular cases.
United States 🇺🇸
Advanced Cardiac SupportThe U.S. heart pump devices market focuses on expanding access to mechanical circulatory support for advanced heart failure management. Healthcare providers continue integrating next-generation devices that improve procedural efficiency and support long-term patient care strategies.
Segment Leadership and Growth Trends
Heart Pump Devices Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Implanted Heart Pump Devices (Largest Segment) vs Extracorporeal Heart Pump Devices (Fastest-Growing Segment)
Implanted heart pump devices held the largest share of the heart pump devices market at 67.03% in 2026, supported by their established role in providing long-term circulatory support for patients with severe cardiac dysfunction. These devices can assist ventricular function and help maintain adequate blood flow when the heart is unable to meet the body's circulatory requirements. Their use in advanced heart failure management, together with improvements in device design, implantation techniques, and patient monitoring, continues to support demand. Increasing emphasis on extending survival and improving quality of life among patients requiring mechanical circulatory support further reinforces the segment's established position.
Extracorporeal heart pump devices are projected to experience the fastest growth, reflecting their importance in situations requiring immediate and temporary cardiovascular support. These systems are particularly valuable during critical care, complex cardiac procedures, and acute conditions where rapid stabilization of circulation is required. Their ability to provide short-term mechanical assistance without permanent implantation makes them suitable for patients with rapidly changing clinical needs. Growing adoption of advanced critical-care interventions and the increasing focus on timely management of severe cardiovascular complications are expected to strengthen demand for extracorporeal systems.
Product Segment Analysis: Ventricular Assist Devices (VADs) (Largest Segment) vs Extracorporeal Membrane Oxygenation (ECMO) (Fastest-Growing Segment)
Ventricular assist devices (VADs) accounted for the largest share of the heart pump devices market at 66.45% in 2026, reflecting their established application in supporting patients with advanced heart failure and impaired ventricular function. VADs can provide mechanical assistance to maintain circulation when the heart's pumping capacity is substantially reduced, making them an important option for long-term or transitional cardiac support. Continued improvements in device miniaturization, implantation procedures, and patient management are supporting broader clinical utilization. The growing burden of advanced cardiovascular disease and increasing demand for therapies that can sustain cardiac function are also reinforcing the segment's market position.
Extracorporeal membrane oxygenation (ECMO) is anticipated to expand at the fastest pace, driven by its ability to provide intensive cardiopulmonary support in critically ill patients. ECMO can temporarily assume or supplement heart and lung function, making it particularly relevant in severe cardiac failure, respiratory complications, and other acute conditions requiring advanced life support. Increasing availability of specialized critical-care capabilities and greater clinical emphasis on rapid intervention are encouraging the use of ECMO in complex cases. Advances in extracorporeal support technologies and growing expertise in managing critically ill patients are further strengthening its adoption.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Implanted Heart Pump Devices, Extracorporeal Heart Pump Devices | Implanted Heart Pump Devices | Extracorporeal Heart Pump Devices |
| Product | Ventricular Assist Devices (VADs), Total Artificial Hearts (TAH), Intra-Aortic Balloon Pumps (IABPs), Extracorporeal Membrane Oxygenation (ECMO) | Ventricular Assist Devices (VADs) | Extracorporeal Membrane Oxygenation (ECMO) |
| End-use | Hospitals, Cardiac Centers, Research Institutes | Hospitals | Cardiac Centers |
Competitive Landscape and Market Positioning
Top players in the heart pump devices market:
1. Abbott Laboratories (United States)
2. Abiomed Inc. (United States)
3. Getinge AB (Sweden)
4. LivaNova PLC (United Kingdom)
5. Berlin Heart GmbH (Germany)
6. SynCardia Systems LLC (United States)
7. Jarvik Heart Inc. (United States)
8. BiVACOR Inc. (United States)
9. Leviticus Cardio Ltd. (Israel)
10. Teleflex Incorporated (United States)
The heart pump devices market is witnessing strong technological progress driven by rising demand for advanced cardiac support systems and minimally invasive treatment solutions. Manufacturers are focusing on compact device designs, enhanced durability, and improved patient monitoring capabilities to support long-term cardiac care. Increasing clinical research activities and healthcare investments are also contributing to product advancement within the market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories (United States) | |||||||
| Abiomed Inc. (United States) | |||||||
| Getinge AB (Sweden) | |||||||
| LivaNova PLC (United Kingdom) | |||||||
| Berlin Heart GmbH (Germany) | |||||||
| SynCardia Systems LLC (United States) | |||||||
| Jarvik Heart Inc. (United States) | |||||||
| BiVACOR Inc. (United States) | |||||||
| Leviticus Cardio Ltd. (Israel) | |||||||
| Teleflex Incorporated (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| J&J | May-26 | The company issued a safety correction regarding its Impella heart pump controller after identifying a technical defect that causes the controller to temporarily stop for 35 seconds. The resulting brief disruption in circulatory support was linked to clinical complications, including two injuries and one death. |
| American College of Cardiology | Mar-25 | The ACC and American Heart Association updated treatment guidelines, upgrading the clinical recommendation of Impella heart pumps in STEMI-related cardiogenic shock from Class 2b to 2a. The revision recognizes improved patient survival benefits, validating the system's role in critical circulatory care. |
| BiVACOR Inc. | Feb-24 | The enterprise secured a USD 13 million grant from the Australian Government’s Medical Research Future Fund via the Artificial Heart Frontiers Program. The non-dilutive capital supports clinical trials, the implementation of a wireless power ecosystem, and long-term controller design optimization for its total artificial heart. |
| CARMAT | Dec-23 | The medical technology company opened its second production facility in Bois-d’Arcy, France, following regulatory approval from notified body DEKRA. This strategic capacity expansion allows the manufacturer to scale production capacity of its Aeson total artificial heart to 500 units annually. |
| Abbott | Apr-23 | The healthcare corporation obtained two expanded clearances from the U.S. FDA for its CentriMag Blood Pump system. The regulatory approvals authorize longer-term clinical use of the pump in adult patients requiring temporary mechanical circulatory support during extended extracorporeal membrane oxygenation (ECMO) procedures. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Heart Pump Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Indication | Bridge-to-Transplant, Bridge-to-Recovery, Destination Therapy, Short-Term Cardiogenic Shock Support |
| Patient Population | Pediatric Patients, Adult Patients with Advanced Heart Failure, Adult Patients with Acute Cardiac Failure |
| Implantation Approach | Open-Chest Implantation, Minimally Invasive Implantation, Percutaneous Implantation |
Heart Pump Devices Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Advanced Heart Failure Care Pathway Analysis |
|
| Patient Access and Reimbursement Landscape |
|
| Next-Generation Heart Pump Innovation Outlook |
|
Need a different cut of the data?
Request Custom ResearchHow big is the heart pump devices market?
What is the expected industry size of heart pump devices by 2036?
How are expanding regulatory approvals influencing adoption in the heart pump devices market?
Why is AI-assisted cardiac diagnostics becoming an important growth driver for the heart pump devices market?
Why do implanted heart pump devices lead the heart pump devices market?
Which product segment is growing fastest in the heart pump devices market?
Why does North America lead the heart pump devices market?
What is driving Asia Pacific growth in the heart pump devices market?
Who are the major participants shaping the heart pump devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization